Petri Dish Market Seeking Excellent Growth | Aicor Medical, NEST Biotechnology, Thermo Fisher Scientific
Petri dishes, also known as cell culture dishes, are ubiquitous glassware used in research and academic laboratories, as well as hospitals, to hold, transfer, and incubate sample substances. A glass petri dish with a lid is used to house an agar culture medium in which bacteria, fungi, and viruses can be grown and researched for various purposes. Microorganisms cannot be culled in a petri dish, but they can be separated from contaminants in the air.
Petri dish
is an important piece of labware in practically all research projects, and many
infectious diseases are detected using a Petri dish-based culture media. Glass
Petri dishes are commonly utilized in numerous scientific activities. However,
depending on the sample, polystyrene plastic Petri dishes are also utilized, as
some substances are incompatible or react with the glass.
The global The petri dish market was worth US$ 155.2 million in 2017, and it is predicted to
grow at a CAGR of 3.6 percent between 2018 and 2026.
The Petri
dish market is being driven by increased research and development in the fields
of proteomics and genomics, as well as the rising prevalence of infectious
diseases and cancer. According to a report issued in 2017 by the International
Federation of Pharmaceutical Manufacturers and Associations, the pharmaceutical
sector spends US$ 149.8 billion on research and development each year.
According to the same source, there are over 7000 substances in the preclinical
stage of development.
However, the The Petri dish market has long been in a mature stage, with little innovation and
no new product introductions from major companies. Non-culture-based diagnostic
tests are rapidly gaining traction in the market, offering faster and more
consistent results than culture-based tests that rely on Petri dishes, which is
projected to limit market expansion. Furthermore, big research laboratories'
adoption of automated liquid handling systems and other lab automation
techniques may stifle the petri dish market's growth. Small-scale manufacturers
in emerging economies create a fierce rivalry in the petri dish sector, which is
also fragmented.
Because
chronic diseases such as cancer, cardiovascular disease, and diabetes are so
common over the world, research efforts in the industrialized world have
shifted to personalized medicine in order to cure them. The market for petri
dishes would be bolstered as a result of these efforts to identify effective
treatment options for this disease. Personalized medicine employs genomes,
proteomics, and cell-based therapies to effectively target disease, increasing
the likelihood of a patient's life. Most of these processes, such as cell
separation and cell culture growth, require the use of a petri dish.
Aicor
Medical, NEST Biotechnology, Thermo Fisher Scientific, Greiner Bio-One,
Corning, Phoenix Biomedical, Millipore Sigma, Reinnervate, Narang Medical
Limited, Biosigma S.r.l., and Pall Corporation are some of the major companies
in the petri dish market.

Comments
Post a Comment